Nothing Special   »   [go: up one dir, main page]

skip to main content
10.1145/3375923.3375942acmotherconferencesArticle/Chapter ViewAbstractPublication PagesicbbeConference Proceedingsconference-collections
research-article

DMBA Induction Increases H-Ras Gene Expression and Decreases CD8 Count in Sprague Dawley Rats

Published: 25 March 2020 Publication History

Abstract

Introduction: DMBA is carcinogenic-immunosuppressant. This study was conducted to investigate the immunosuppressant effect of dimethylbenzanthracene (DMBA) on H-Ras expression, hemogram, and CD8 count I Sprague Dawley (SD) rats. Methods: We divided the test animals into three groups. The normal group received standard food and drink. We induced the DMBA group with 10x20mg/kg BW DMBA for five weeks. The solvent group received standard feeding and corn oil solutions. We conducted dissection and data retrieval in week 27. The immunosuppressant effects of DMBA are measured by number leukocytes and CD8CTL. The number of CD8 is determined by the flow cytometer. The H-Ras gene expression is assessed using densitometry after PCR. The mean intergroup difference was calculated using ANOVA. Result: The results showed that DMBA administration increases H-Ras gene expression and decreases CD8 count (p<0.05). 10x20 mg/kg BW DMBA administration decrease leukocytes and platelet (p<0.05). Conclusion: A dose of 10x20 mg/kg BW DMBA decreased CD8, leukocytes, and platelet number, while it increased H-Ras gene expression in SD rats.

References

[1]
Gao, J, Lauer, F.T., Dunaway, S., Burchiel, S.W. 2005. Cytochrome P450-1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci. 2005 Jul;86(1):68--74. Epub 2005 Apr 20
[2]
Pahria, T. 2017. Indonesian women diagnosed with breasycancer: A hermeneutic process. Thesis. School of Nursing Faculty of Health Queensland University of Technology
[3]
Ghoncheh, M., Mahdavifar, N., Darvishi, E., Salehiniya, H., 2016. Epidemiology, Incidence and Mortality of Breast Cancer in Asia, Asian Pacific Journal of Cancer Prevention, Vol 17
[4]
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., . . . Bray, F. 2014. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. Visit: http://globocan. iarc. fr.
[5]
Bajak, E.Z., 2005. Genotoxicstress:novel biomarkers and detection methods uncovering RNAs role in epigenetics of carcinogenesis, Dissertation, Karolinska University Press, Sweden
[6]
Arora, A, Siddiqui, I.A., Shukla, Y., 2004. Modulation of p53 in 7,12- dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice, Mol Cancer Ther.,3(11):1459--66
[7]
Ahn, J., Xia, T., Konno, H., Konno, K., Ruiz, P., Barber, G.N., 2014. Inflammation-driven carcinogenesis is mediated through STING, NATURE COMMUNICATIONS, 5:5166; | www.nature.com/naturecommunications
[8]
Gao, J, Lauer, F.T., Mitchell, L.A., Burchiel, S.W., 2007. Microsomal expoxide hydrolase is required for 7,12-dimethylbenz[a]anthracene (DMBA)-induced immunotoxicity in mice. Toxicol Sci. 2007 Jul;98(1):137--44. Epub 2007 Apr 18.
[9]
Grivennikov, S.I., Greten, F.R., Michael Karin, K., 2010. Immunity, Inflammation, and Cancer, Cell 140, 883--899, March 19, 2010
[10]
Melendez-Colon, V.J., Luch, A., Seidel, A., Baird, W.M., 2000. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures, Chem Res Toxicol., 13(1), 10--17 11. Fernandes, J.V., Cobucci, R.N.O., Jatobá, C.A.N., de Medeiros Fernandes, T.A.R., de Azevedo, J.W.V., de Araújo, J.M.G., 2015. The Role of the Mediators of Inflammation in Cancer Development, Pathol. Oncol. Res.DOI 10.1007/s12253-015-9913-z
[11]
Miyata M, Furukawa M, Takahashi K, Gonzalez FJ, Yamazoe Y., 2001. Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ, Jpn J Pharmacol. 2001 Jul; 86(3):302--9.
[12]
Pitot, H.C., and Dragan, Y., P., 2001, Chemical Carcinogenesis, in Curtis D Klaasen, Casarett&Doull's: Toxicology, The Basic Science of Poisons, 6th ed, Mc. Graw Hill. Medical Publishing Division, New York, p. 241--280.
[13]
Barletta, E., G. Gorini, P. Vinels, L. Miligi, L. Davico, G. Mugnai, S. Ciolli, F. Leoni, M. Bertini, G. Matullo, and A. S. Costantini. 2004. Ras gene mutations in patients with acute myeloid leukemia and exposure to chemical agents. Carcinogenesis, 25(5), 749--755
[14]
Shimada, T., 2006. Xenobiotic - metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbon, Drug. MetabPharmacocinet, 27(4), 257--27
[15]
Melendez-Colon, V.J., Luch, A., Seidel, A., Baird, W.M., 1999. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites, Carcinogenesis. 20(10), 1885--1891
[16]
Page, T.J., O'Brien, S., Holstone, K., William, P.S., Jefcoat, C.R., 2003. 7,12-dimethylbenz[a]anthracene-Induced Bone Marrow ToxicityIs p53-Dependent, Toxicol Sci. 74: 85--92
[17]
Dobrovolsky, V.N., Revollo, J., Pearce, M.G., Pacheco-Martinez, M.M. and Lin, H. 2015. CD48-Deficient T-Lymphocytes from DMBA-Treated Rats Have De Novo Mutations in the Endogenous Pig-a Gene, Environ. Mol. Mutagen. 56:674--683, 2015.
[18]
Xia, T., Konno, H., Ahn, J., Barber, G.N. 2016. Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis, Cell Reports 14, 282--297, January 12, 2016
[19]
Kim, R., Emi, M., Tanabe, K., 2007. Cancer immunoediting from immune surveillance to immune escape, Immunology. 121:1--14
[20]
Abbas, A.K., Lichtman, A. H., and Pober, J. S. 2016. Celluler and Molecular Immunology. Second Ed. Philadelphia: W.B. Sounders Company
[21]
Nasti, T.H., Rudemiller, K.J., Cochran, J.B., Kim, H.K., Tsuruta, Y., Fineberg, N.S., Athar, M., Elmets, C.A., and Timares, L. 2015. Immunoprevention of Chemical Carcinogenesis through Early Recognition of Oncogene Mutations, The Journal of Immunology, 2015, 194: 2683--2695
[22]
Braun, M.W. and Iwakuma, T. 2016. Regulation of cytotoxic T-cell responses by p53 in cancer, Transl Cancer Res. 2016 December; 5(6): 692--697.
[23]
Rousalova, I., and Krepela, E. 2010. Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int J Oncol. 2010 Dec;37(6):1361--78. Review
[24]
Chang, J., Hung, L., Chyan, Y., Cheng, C., and Wu, R. 2011. Carthamustinctorius Enhances the Antitumor Activity of Dendritic Cell Vaccines via Polarization toward Th1 Cytokines and Increase of Cytotoxic T Lymphocytes, Evidence-Based Complementary and Alternative Medicine Volume 2011, Article ID 274858, 10 pages
[25]
Ribas, A., 2007. Tremelimumab (CP-675, 206), a Cytotoxic T Lymphocyte-Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer, Oncology. 12 (7): 873--883
[26]
Thiery, J., Abouzahr, S., Dorothee, G., Jalil, A., Richon, C., Vergnon, I., Mami-Chouaib, F., and Chouaib, S. 2005. p53 Potentiation of Tumor Cell Susceptibility to CTL Involves Fas and Mitochondrial Pathways, The Journal of Immunology, 2005, 174: 871--878
[27]
Thiery, J., Dorothe´e, G., Haddada, H., Echchakir, H., Richon, C., Stancou, R., Vergnon, I., Benard, J., Mami-Chouaib, F., Chouaib, S. 2003. Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function, The Journal of Immunology, 2003, 170: 5919--5926
[28]
Meslin, F., Thiery, T., Richon, C., Jalil, A. and Chouaib, S. 2007. Granzyme B-induced Cell Death Involves Induction of p53 Tumor Suppressor Gene and Its Activation in Tumor Target Cells, Journal of Biological Chemistry, volume 282•number 45•november 9, 2007
[29]
Corrales, L., Glickman, L.H., Dubensky, T.W., Gajewsk, T.F., 2015. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity, Cell Reports 11, 1018--1030
[30]
Roulois, D., Grégoire, M., and Fonteneau, J. 2013. MuC1-T lymphocytes in cancer Therapy Induction and Challenge, BioMed Research International Volume 2013, Article ID 871936, 10 pages http://dx.doi.org/10.1155/2013/871936
[31]
Surh, Y., 2003. Cancer Chemoprevention With Dietary Phytochemicals. Nature Revs.3.; 768--80
[32]
Akrom, E. Darmawan, L.Yuhelvia., 2015. Black Cumin Seed Oil as Hepatoprotector in Decreasing SGPT/SGOT Activity and Increasing p53 Gene Expression in Sprague Dawley Rats Induced by Alloxan, International Journal of Public Health Science (IJPHS) Vol.4. No.3. Septernber 2015. pp. I59--163
[33]
Jefri, S.H., Glass, J., Shi, R., Zhang, S., Prince, M., Kleiner-Hancock, H., 2010. Thymoquinone and cisplatin as therapeutic combination in lung cancer: in vitro and in vivo, J Exp clin cancer res. 29(87): 1--11
[34]
Li, F., Rajendran, P., Sethi, G., 2010. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. Br J Pharmacol. 161(3):541--54.
[35]
Hussain, A.R., Ahmed, M., Ahmed, S., Manogaran, P., Platanias, L.C., Alvi, S.N., Al-Kuraya, K.S., Uddin, S., 2011. Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma., Free RadicBiol Med. 15;50(8):978--87
[36]
Badary OA, Abd-Ellah MF, El-Mahdy MA, Salama SA, Hamada FM, 2007. Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice, Food ChemToxicol, 45(1):88--92
[37]
Badary OA, Gamal El-Din AM, 2001. Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis., Cancer Detect Prev., 25(4): 362--8
[38]
Mohany, M., El-Feki, M., Refaat, I., Garraud, O., Badr, G. 2012. Thymoquinone ameliorates the immunological and histological changes induced by exposure to imidacloprid insecticide. J Toxicol Sci. 37(1):1--11
[39]
Salem, M.L., Alenzi F.Q., Attia W.Y. 2011. Thymoquinone, the active ingredient of Nigella sativa seeds, enhances survival and activity of antigen-specific CD8-positive T cells in vitro. Br J Biomed Sci. 68(3):131--7
[40]
Majdalawieh, A.F., Hmaidan, R., Carr, R.I., 2010. Nigella sativa modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity., J Ethnopharmacol. 131(2):268--75.
[41]
Akrom&Mustofa, 2017. Black cumin seed oil increases phagocytic activity and secretion of IL-12 by macrophages, Biomedical Research 2017; 28 (12): 5241--5246
[42]
El Sayed I and Fukushima S, 2003. Chemopreventive potential of volatile oil from black cumin (Nigella sativa L) seeds against rat colon carcinogenesis. J. of Nutrit and Cancer. 45 (2):195--202
[43]
Deng, W., Fu, Y., Li, Y., Sugiyama, T., 2004. Potential role of p53 mutation in chemical hepatocarcinogenesis of rats, World J Gastroenterol. 10(1):46--52
[44]
Walentinsson, A., and Levan, G., 2001. Ras gene mutations in 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat sarcomas, Cancer Lett. 166(1): 47--53
[45]
Luceri, C., Caderni, G., Sanna, A., Dolara, P., 2002. Red Wine and Black Tea Polyphenols Modulate the Expression of Cycloxygenase-2, Inducible Nitric Oxide Synthase and Glutathione-Related Enzymes in Azoxymethane-Induced F344 Rat Colon Tumors, J Nutr. 132: 1376--1379
[46]
Kubatka, P., Ahlersova E., Ahlers I., Bojkova B., Kalicka K., Adamekova E., Markova M., Chamilova M. and Cermakova M., 2002, Variability of Mammary Carsinogenesis Induction in Female Sprague-Dawley and Wistar: Han Rats: the Effect of Season and Age, Physiol. Res., 51, 633--640
[47]
Horn, T.L., Torres, K.E., Naylor, J.M., Cwik, M.J., Detrisac, C.J., Kapetanovic, I.M., Lubet, R.A., Crowell, J.A., McCormick, D.L., 2007. Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate +bexarotene in female rats. Toxicol Sci. 2007 Oct. 99(2):612--27
[48]
Mousa, D., Dilsiz, N., Gumushan, H., 2004. Antitumor activity of an ethanol extract of Nigella sativa seeds, Biologia-Bratislava, 59(6):735--40
[49]
Mbarek, L.A., H. Ait Mouse, H.I., Elabbadi, Bensalah, M., Gamouh, A., Aboufatima, R., Benharref, A., Chait, A., M. Kamal, M., Dalal, A., and Zyad, A., 2007. Anti-tumor properties of blackseed (Nigella sativa L.) extracts, Braz J Med Biol Res. 40(6):839--47
[50]
Sethi, G., Ahn, K.S., Aggarwal, B.B., 2008. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 6(6):1059--70.
[51]
Lacroix, M., Toillon, R.A., Leclercq, G., 2006. P53 and breast cancer, an update, Endocrine-related canc. 13: 293--325
[52]
Woo, S., Fuertes, M.B., Corrales, L., Spranger, S., Furdyna, M.J., Leung, M.Y.K., Duggan, R., Wang, Y., Barber, G.N., Fitzgerald, K.A., Alegre, M., Gajewski, T.F. 2014. STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors, Immunity 41, 830--842, November 20, 2014
[53]
Whiteside, T.L., 2008. The tumor microenvironment and its role in promoting tumor growth, Oncogene. 27: 5904--5912
[54]
Swann, J.B., Vesely, M.D., Silva, A., Sharkey, J., Akira, S., Schreiber, R., Smyth, M., 2008. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis, PNAS. 105(2): 652--6
[55]
Swann, J.B. and Smyth, M.J., 2007. Immune surveillance of tumor, J. Clin. Invest. 117(5): 1137--46
[56]
Hehmann-Titt, G., Schiffer, S., Berges, N., Melmer, G., and Barth, S.2013. Improving the Therapeutic Potential of Human Granzyme B for Targeted Cancer Therapy, Antibodies 2013, 2, 19--49;
[57]
Al Ghamdi MS, 2001. The antiinflamator, analgesic and antipyretic activity of Nigella sativa, 55: 379--382. Departemen of Pharmacology King Faisal University Collage of Medicine. www.elseiver.com. Desember 2002
[58]
Salem, M.L., 2005. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed, International Immunopharmacol. 5:1749--1770
[59]
Naseemuddin, M., Iqbal, A., Nasti, T.H., Ghandhi, J.L.Kapadia, A.D., Yusu, N., 2012. Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice, Int. J. Cancer: 130, 765--774
[60]
Rahman, PNR., Akrom, A., Darmawan, E., 2018. The efficacy of black cumin seed (Nigella sativa) oil and hypoglycemic drug combination to reduce HbA1c level in patients with metabolic syndrome risk, IOP Conf. Series: Materials Science and Engineering 259 (2017) 012018
[61]
Akrom, A. & Darmawan, E., 2017. Tolerability and safety of black cumin seed oil (Bcso) administration for 20 days in healthy subjects. Biomedical Research 2017; 28 (9): 4196--4201, 2017
[62]
Titiek Hidayati, Akrom, Indrayanti, Sagiran, 2019. Chemopreventive effect of black cumin seed oil (BCSO) by increasing p53 expression in dimethylbenzanthracene (DMBA)-induced Sprague Dawley rats

Index Terms

  1. DMBA Induction Increases H-Ras Gene Expression and Decreases CD8 Count in Sprague Dawley Rats

    Recommendations

    Comments

    Please enable JavaScript to view thecomments powered by Disqus.

    Information & Contributors

    Information

    Published In

    cover image ACM Other conferences
    ICBBE '19: Proceedings of the 2019 6th International Conference on Biomedical and Bioinformatics Engineering
    November 2019
    214 pages
    ISBN:9781450372992
    DOI:10.1145/3375923
    Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

    In-Cooperation

    • East China Normal University

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    Published: 25 March 2020

    Permissions

    Request permissions for this article.

    Check for updates

    Author Tags

    1. CD8
    2. DMBA
    3. H-Ras Gene
    4. immunosuppressant

    Qualifiers

    • Research-article
    • Research
    • Refereed limited

    Conference

    ICBBE '19

    Contributors

    Other Metrics

    Bibliometrics & Citations

    Bibliometrics

    Article Metrics

    • 0
      Total Citations
    • 35
      Total Downloads
    • Downloads (Last 12 months)0
    • Downloads (Last 6 weeks)0
    Reflects downloads up to 05 Jan 2025

    Other Metrics

    Citations

    View Options

    Login options

    View options

    PDF

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    Media

    Figures

    Other

    Tables

    Share

    Share

    Share this Publication link

    Share on social media